angiography or computed tomography. We compared the outcomes of SFA angioplasty with versus without combined BTKI. Results: More limbs treated with BTKI showed absence of any run-off vessel before angioplasty (56% vs 19%, p< 0.001). Other baseline characteristics were similar. SFA lesion length did not differ between the limbs with and without BTKI (226AE101 vs 248AE72 mm, p¼0.214). At 1-year follow-up, overall mortality rate was 14% and 7% for patients with and without BTKI, retrospectively (p¼0.235). There was no major amputation in both groups. Unexpected minor amputation rate was 11% and 3%, respectively (p¼0.120). Target vessel revascularization rate for limbs with BTKI was 18% versus 11% for limbs without BTKI (p¼0.292). Kaplan-Meier analysis showed limbs with BTKI have a lower 1 year patency rate (log rank p¼0.032) than those without BTKI.
Background: Femoropoliteal in-stent restenosis (FP-ISR) is associated with high rates of recurrent stenosis and stent occlusion after endovascular therapy. Laser atherectomy provides neointimal debulking and possible subsequent improved patency in the treatment of FP-ISR. Methods: All cases of FP-ISR treated between 2006-2013 were retrospectively identified. FP-ISR was divided into three angiographic classes: Class I ( 50 mm length); Class II (>50 mm length); and Class III (in-stent occlusion). Baseline demographics and lesion angiographic characteristics were compared between groups. Recurrent stenosis, as assessed by duplex ultrasound, was determined routinely at 3-4 month intervals up to 24 months post-intervention. Results: One hundred and eighteen patients underwent endovascular treatment of FP-ISR. Thirty-seven patients (31%) were treated with laser atherectomy and balloon angioplasty, while 81 patients were treated with balloon angioplasty. Patients treated with laser atherectomy had longer mean lesion length of FP-ISR (185 mm vs. 116 mm, p¼0.001) and were more likely to have Class III ISR (54% vs. 20%, p¼0.001) and TASC C/D lesions (64% vs. 35%, p¼0.007). Procedural success was achieved in 100% of laser-assisted cases and 98% of non-laser-assisted cases. Complication rates were low, with four distal embolizations in the laser group and one in the non-laser group (p¼0.01). There was no association between laser atherectomy and rates of recurrent stenosis or occlusion for patients with Class I or Class II FP-ISR. In comparison, patients with Class III FP-ISR treated with laser atherectomy were less likely to develop recurrent stenosis at one year (54% vs. 91%, p¼0.05) and two year (69% vs. 100%, p¼0.05) follow-up.
Conclusions: Laser atherectomy with adjunctive balloon angioplasty may be associated with improved patency when used to treat complex FP-ISR, including longer lesions and in-stent occlusions. Saiseikai Yokohama-City Eastern Hospital, Yokohama, Japan Background: It has not been reported that intravascular ultrasound (IVUS) findings correlate with drug eluting stent (DES) restenosis after endovascular therapy for femoropopliteal lesions. So we investigated that in this study. Methods: This was a single center non-randomized retrospective study. From April 2012 to March 2013, a total of 71 consecutive de novo femoropopliteal lesions in patients who underwent intravascular ultrasound (IVUS) after DES implantation were included. The mean follow-up period was 12AE4 months. In-stent restenosis (ISR) was defined as a peak systolic velocity ratio >2.4 on duplex ultrasonography or >75% stenosis on angiography. ISR were detected in 14 lesions (19.7%). Subjects were classified into two groups: the patients with ISR (ISR group, 14 lesions, 12 patients) and without ISR (non-ISR group, 57 lesions, 49 patients). We compared post-procedural IVUS findings between two groups. Results: For baseline patients and lesion characteristics, the percentage of women was higher in ISR group than non-ISR group (83.3% vs. 20 (54) 17 (20) www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5 :00 PM-7:00 PM JACC Vol 64/11/Suppl B j September 13-17, 2014 j TCT Abstracts/Iliac and SFA B159
